Acticor Biotech (XPAR:ALACT) Total Assets : €14.30 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Total Assets?

Acticor Biotech's Total Assets for the quarter that ended in Jun. 2023 was €14.30 Mil.

During the past 12 months, Acticor Biotech's average Total Assets Growth Rate was -1.20% per year. During the past 3 years, the average Total Assets Growth Rate was 36.10% per year. During the past 5 years, the average Total Assets Growth Rate was 37.40% per year.

During the past 6 years, Acticor Biotech's highest 3-Year average Total Assets Growth Rate was 75.10%. The lowest was 19.80%. And the median was 36.10%.

Total Assets is connected with ROA %. Acticor Biotech's annualized ROA % for the quarter that ended in Jun. 2023 was -148.01%. Total Assets is also linked to Revenue through Asset Turnover. Acticor Biotech's Asset Turnover for the quarter that ended in Jun. 2023 was 0.00.

Acticor Biotech Total Assets Historical Data

The historical data trend for Acticor Biotech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech Total Assets Chart

Acticor Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Assets

Get a 7-Day Free Trial

11.41

15.40

11.02

17.88

12.94

Acticor Biotech Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Assets	Get a 7-Day Free Trial				13.17	17.88	11.32	12.94	14.30

Acticor Biotech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Acticor Biotech's Total Assets for the fiscal year that ended in Dec. 2022 is calculated as

Total Assets	=	Total Equity (A: Dec. 2022 )	+	Total Liabilities (A: Dec. 2022 )
	=	-2.243	+	15.186
	=	12.94

Acticor Biotech's Total Assets for the quarter that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2023 )	+	Total Liabilities (Q: Jun. 2023 )
	=	0.368	+	13.934
	=	14.30

Acticor Biotech (XPAR:ALACT) Total Assets Explanation

Total Assets is connected with ROA %.

Acticor Biotech's annualized ROA % for the quarter that ended in Jun. 2023 is

ROA %	=	Net Income (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
	=	-20.162	/	( (12.943	+	14.302)	/ 2 )
	=	-20.162	/	13.6225
	=	-148.01 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Acticor Biotech's Asset Turnover for the quarter that ended in Jun. 2023 is

	Asset Turnover
=	Revenue (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
=	0	/	( (12.943	+	14.302)	/ 2 )
=	0	/	13.6225
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Acticor Biotech Total Assets Related Terms

Thank you for viewing the detailed overview of Acticor Biotech's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Acticor Biotech (XPAR:ALACT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

7V7:Germany

Address

82 Avenue du Maine, Wojo Building, Paris, FRA, 75014

Website

https://www.acticor-biotech.com

Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines